STTR Phase II: Developing High Carotenoid Orange Corn for Large-scale Commercial Adoption
STTR 第二阶段:开发高类胡萝卜素橙玉米以进行大规模商业应用
基本信息
- 批准号:1926952
- 负责人:
- 金额:$ 74.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development and commercialization of a novel variety of corn that is high in carotenoids and orange in color, and with yields that are competitive with today's commercial hybrids. In the diets of Americans, two important antioxidant carotenoids, lutein and zeaxanthin, are in low abundance. This deficiency has been associated with higher risk for degenerative diseases such as age-related macular degeneration, and potentially, dementia. The ultimate goal of the proposed research is to provide a way for Americans to consume more lutein and zeaxanthin, which will be achieved by increasing significantly the levels of these antioxidants in the U.S.'s most widely grown staple crop: Corn. Since corn is used in a wide variety of popular processed food formats, improving the carotenoid content of corn provides an opportunity to significantly increase the amount of health benefiting antioxidants that Americans consume, without changing consumers eating habits. However, in order for this strategy to be economically feasible, corn varieties that are high in carotenoids must be developed that also are high in grain yield. This STTR Phase II project proposes to use genetic markers to select for favorable alleles of genes associated with carotenoid biosynthesis and stability in corn bred for commercial production. There is considerable genetic variation in genes associated with carotenoid biosynthesis and stability, however, the most favorable alleles are typically not found in varieties that are commercially relevant to US corn production. Thus, the use of genetic markers developed previously will enable favorable alleles to be moved from lower yielding germplasm that is not well adapted to the US Corn Belt into elite inbreds suitable for the production of yield-competitive commercial F1 hybrids for the US market. The primary goal of this Phase II research is to use the user-friendly genetic markers associated with favorable alleles for 18 key genes associated with carotenoid biosynthesis and stability developed in Phase I to rapidly develop fixed inbreds for use in the production of yield-competitive high carotenoid F1 hybrids suitable for large-scale commercial applications.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该小企业技术转让 (STTR) 项目的更广泛影响/商业潜力将是开发和商业化一种新型玉米品种,该品种富含类胡萝卜素,颜色为橙色,其产量可与当今的商业杂交品种相媲美。在美国人的饮食中,两种重要的抗氧化剂类胡萝卜素——叶黄素和玉米黄质——的含量很低。这种缺陷与退行性疾病(如年龄相关性黄斑变性)和潜在的痴呆症的较高风险有关。拟议研究的最终目标是为美国人提供一种摄入更多叶黄素和玉米黄质的方法,这将通过显着提高美国种植最广泛的主粮作物玉米中这些抗氧化剂的水平来实现。由于玉米用于多种流行的加工食品中,提高玉米的类胡萝卜素含量提供了一个机会,可以在不改变消费者饮食习惯的情况下显着增加美国人消耗的有益健康的抗氧化剂的量。然而,为了使这一策略在经济上可行,必须开发类胡萝卜素含量高且谷物产量高的玉米品种。 STTR II 期项目建议使用遗传标记来选择与类胡萝卜素生物合成和商业生产玉米稳定性相关的有利等位基因。与类胡萝卜素生物合成和稳定性相关的基因存在相当大的遗传变异,然而,在与美国玉米生产商业相关的品种中通常找不到最有利的等位基因。因此,使用先前开发的遗传标记将使有利的等位基因从不太适应美国玉米带的低产种质转移到适合为美国市场生产具有产量竞争性的商业F1杂种的优良近交系中。这项 II 期研究的主要目标是利用与 I 期开发的类胡萝卜素生物合成和稳定性相关的 18 个关键基因的有利等位基因相关的用户友好的遗传标记,快速开发固定自交系,用于生产适合大规模商业应用的产量竞争性高类胡萝卜素 F1 杂交种。该奖项反映了 NSF 的法定使命,并被认为值得通过 使用基金会的智力价值和更广泛的影响审查标准进行评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Evan Rocheford其他文献
Evan Rocheford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Evan Rocheford', 18)}}的其他基金
STTR Phase I: Utilizing Natural Variation to Increase the Antioxidant Carotenoid Content in High Yielding Corn Varieties
STTR 第一阶段:利用自然变异提高高产玉米品种的抗氧化类胡萝卜素含量
- 批准号:
1721692 - 财政年份:2017
- 资助金额:
$ 74.74万 - 项目类别:
Standard Grant
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
STTR Phase II: Fabrication and Structural Testing of a 3D Concrete Printed Anchor for Floating Offshore Wind
STTR 第二阶段:用于浮动海上风电的 3D 混凝土打印锚的制造和结构测试
- 批准号:
2333306 - 财政年份:2024
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
- 批准号:
2332121 - 财政年份:2024
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Earth-abundant catalyst for power-to-liquids chemical production at the kiloton scale
STTR 第二阶段:地球储量丰富的催化剂,用于千吨级电力转化为液体的化学生产
- 批准号:
2304275 - 财政年份:2024
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images
STTR II 期:通过高分辨率全身图像对可疑色素性皮肤病变进行皮肤科医生级别的检测
- 批准号:
2335086 - 财政年份:2024
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Thermal Imaging, Augmentation of Microwave Energy in Various Tissues and Chronic Safety
STTR 第二阶段:热成像、增强各种组织中的微波能量和长期安全性
- 批准号:
2301440 - 财政年份:2024
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Nanomaterial-based Residual Active Disinfectant for Decreasing Surface Acquired Infections
STTR 第二阶段:基于纳米材料的残留活性消毒剂,用于减少表面获得性感染
- 批准号:
2208717 - 财政年份:2023
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Scaling the Purification of Mycosporine-like Amino Acids to Replace Chemical Ultraviolet (UV) Filters and Protect Human and Environmental Health.
STTR 第二阶段:扩大类菌孢素氨基酸的纯化,以取代化学紫外线 (UV) 过滤器并保护人类和环境健康。
- 批准号:
2222582 - 财政年份:2023
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Stem Cell Delivery in Microscopic Hydrogel Droplets for Faster and More Complete Healing of Equine Tendon and Ligament Injuries
STTR 第二阶段:以微小水凝胶液滴形式输送干细胞,以更快、更完全地治愈马肌腱和韧带损伤
- 批准号:
2304324 - 财政年份:2023
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Development of a Smart Remote Health Management System for Patients with Kidney Disease
STTR二期:为肾病患者开发智能远程健康管理系统
- 批准号:
2243718 - 财政年份:2023
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement
STTR Phase II: Body fluid identification for forensic purposes using Raman spectroscopy
STTR 第二阶段:使用拉曼光谱法进行体液鉴定
- 批准号:
2304318 - 财政年份:2023
- 资助金额:
$ 74.74万 - 项目类别:
Cooperative Agreement














{{item.name}}会员




